on NANOBIOTIX (EPA:NANO)
The Goldman Sachs Group reduces its stake in NANOBIOTIX
The Goldman Sachs Group, Inc. announced that it crossed below the 5% threshold of voting rights in NANOBIOTIX on November 10, 2025. This decrease resulted from an off-market sale of shares. The company currently holds 5.19% of the share capital, representing 4.97% of the voting rights of NANOBIOTIX.
Shares held directly or through incorporation amount to 2,502,504, primarily distributed through Goldman Sachs International. A securities lending arrangement represents 2,308,736 shares, with a right of recall. In addition, four swap contracts allow the holder to hold 50,043 shares through incorporation.
These moves are taking place within the context of a strategic refinancing for the financial group, which is seeking to optimize its asset portfolio.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NANOBIOTIX news